Abstract
In diabetes mellitus, insulin-producing beta cells in the pancreas are lost (type 1) or dysfunctional (type 2). Cell replacement therapy has emerged as a promising alternative to insulin injection for treatment of diabetic patients. Given the scarcity and difficulty in obtaining pancreatic beta cells from cadaveric donors, current research is aiming at the generation of functional beta cells from non-beta-cell sources or from pluripotent progenitors such as adult or embryonic stem cells. However, to achieve this, we first need to understand how beta cells are formed during normal development. Knowledge of the molecular and genetic pathways that direct cells along their differentiation pathway will be instrumental if we aim to engineer new beta cells for clinical use. This article reviews pancreatic development from a gene expression point of view and discusses our current understanding of the transcription factors that rule pancreatic morphogenesis during ontogeny.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.